Up Over 35% This Month: Is Nuvei Stock a Buy Right Now?

Given its high growth prospects and cheaper valuation, the uptrend in Nuvei will continue.

| More on:

On Tuesday, Statistics Canada announced that the Consumer Price Index rose 3.1% in October from its previous year. It was lower than analysts’ expectations of 3.2% and September’s 3.8%. With the signs of inflation easing, investors could expect the central bank to ease its monetary tightening initiatives. Amid the optimism, the Canadian equity markets are upbeat this month, with the S&P/TSX Composite Index rising 6.6%.

Meanwhile, growth stocks are back on focus with improving investors’ sentiments. Nuvei (TSX:NVEI), which reported a solid third-quarter performance earlier this month, is trading 38.4% higher this month, outperforming the broader equity markets. Despite the recent surge, it is down 55% from its 52-week high. So, let’s assess whether the stock is still a buy by looking at its recent third-quarter performance and growth prospects.

Nuvei’s third-quarter performance

In the third quarter, Nuvei reported revenue of $304.9 million, representing 55% year-over-year growth. Solid organic growth, strategic acquisitions, and favourable currency translation drove its financials. The company processed $48.2 billion of transactions during the quarter, representing 72% year-over-year growth. Organic growth at a constant currency contributed around 20% of the volume growth. Meanwhile, e-commerce dominated, representing approximately 88% of the total transactions.

Despite the topline growth, the company incurred a net loss of $18.1 million against net profits of $13 million in the previous year’s quarter. However, removing special items, its adjusted net income stood at $56.8 million, a 9% decline from the previous year’s quarter. Higher finance, depreciation, and amortization expenses dragged its adjusted net income down. Meanwhile, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) grew 36% to $110.7 million. However, its adjusted EBITDA margin fell 490 basis points to 36.3%.

Amid its initiatives to strengthen its balance sheet, the company’s leverage ratio (net debt/trailing 12 months adjusted EBITDA) declined to 2.6 compared to 2.8 in the previous quarter. Now, let’s look at its growth prospects.

Nuvei’s growth prospects

Nuvei focuses on expanding its product offerings, venturing into new markets, and expanding its APM (alternative payment methods) portfolio to add new customers and grow wallet share with existing customers. By the end of the third quarter, the company supported 669 APMs. Besides, it opened a new office in China to expand its footprint across the Asia-Pacific region.

Amid its continued strong operational performance, Nuvei’s management has raised its guidance for this year. The midpoint of its 2023 revenue and adjusted EBITDA guidance represent 40.5% and 22.7% growth from the previous year, respectively. In the medium term, the company hopes to grow its revenue at 15–20% annually while making capital investments of 4–6% of its revenue. Also, the company’s management is optimistic about achieving an adjusted EBITDA margin of above 50% in the long run. So, the company’s outlook looks healthy.

Investors’ takeaway

Despite the healthy buying this month, Nuvei trades at NTM (next 12 months) price-to-sales and NTM price-to-earnings multiples at 2 and 9.7, respectively. Given its high growth prospects, I believe the company is trading at a cheaper valuation, making it an attractive buy. Besides, it also pays a quarterly dividend of $0.10/share. 

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei. The Motley Fool has a disclosure policy.

More on Tech Stocks

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold In 2026

Down over 50% from all-time highs, Well Health stock offers significant upside potential to shareholders in December 2025.

Read more »

container trucks and cargo planes are part of global logistics system
Stocks for Beginners

TFSA: 3 Premier Canadian Stocks for Your $10,000 Contribution

Invest in your future with high quality Canadian stocks for your TFSA. Discover three stocks offering significant growth potential.

Read more »

Female raising hands enjoying vacation, standing on background of blue cloudless sky.
Tech Stocks

If You Were Waiting for Tech Stocks to Go on Sale, Now’s Your Chance

Tech stocks, like Constellation Software (TSX:CSU), might be terrific bargains amid volatility.

Read more »

visualization of a digital brain
Tech Stocks

The AI Stocks I’m Seriously Considering After the Tech Wreck

Shopify (TSX:SHOP) stock is a seriously impressive stock that just had a great Black Friday.

Read more »

Engineers walk through a facility.
Tech Stocks

TFSA Investors: How to Invest $7,000 in 2026?

TFSA investors should consider investing in diversified index funds and undervalued growth stocks to derive inflation-beating returns.

Read more »

gift is bigger than the other
Tech Stocks

1 Oversold TSX Tech Stock to Buy and Hold in December 2025

Down almost 55% from its 52-week high, CMG is a TSX tech stock that offers significant upside potential in December…

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Dividend Stocks

This Under-the-Radar Tech Stock Can Be Canada’s Next Unicorn

This under-the-radar Canadian power-tech supplier rides AI data centres and electrification, and could quietly compound into a unicorn.

Read more »

investor looks at volatility chart
Tech Stocks

This Soaring Canadian AI Stock Still Trades at a 33% Discount in December 2025

Down 14% from all-time highs, Celestica is an AI stock that trades at a discount to consensus price targets in…

Read more »